Fund
| Item | Value |
|---|---|
| Ticker (pseudo) | FGRH |
| CUSIP | Not applicable (hypothetical model portfolio) |
| Listing exchange | Not listed (hypothetical) |
| Underlying model | Gross Margin factor (Healthcare only) |
| Placeholder expense ratio | 0.45% |
Loading the page
| Item | Value |
|---|---|
| Ticker (pseudo) | FGRH |
| CUSIP | Not applicable (hypothetical model portfolio) |
| Listing exchange | Not listed (hypothetical) |
| Underlying model | Gross Margin factor (Healthcare only) |
| Placeholder expense ratio | 0.45% |
| Placeholder inception date |
| 2019-11-19 |
| Number of holdings (long leg) | 72 |
| Weighting | Cap-weighted |
| Rebalance frequency | Monthly |
| Holdings as of | November 2026 |
| # | Ticker | Company | Sector | Weight | Market Value | CUSIP |
|---|---|---|---|---|---|---|
| 1 | RPRX | ROYALTY PHARMA PLC | Healthcare | 14.90% | $14,900,645 | HYP-RPRX |
| 2 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 14.37% | $14,366,413 | HYP-RVMD |
| 3 | THC | TENET HEALTHCARE CORP | Healthcare | 8.60% | $8,599,012 | HYP-THC |
| 4 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 6.46% | $6,458,091 | HYP-NBIX |
| 5 | EXEL | EXELIXIS INC | Healthcare | 6.42% | $6,418,657 | HYP-EXEL |
| 6 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 4.09% | $4,089,112 | HYP-KYMR |
| 7 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3.30% | $3,303,546 | HYP-PTGX |
| 8 | CORT | CORCEPT THERAPEUTICS INC | Healthcare | 3.04% | $3,038,426 | HYP-CORT |
| 9 | ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | 2.51% | $2,508,488 | HYP-ARWR |
| 10 | IBRX | IMMUNITYBIO INC | Healthcare | 2.43% | $2,432,142 | HYP-IBRX |
| 11 | SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | 1.98% | $1,983,295 | HYP-SRRK |
| 12 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 1.96% | $1,961,487 | HYP-DNTH |
| 13 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 1.86% | $1,864,163 | HYP-TVTX |
| 14 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 1.71% | $1,713,091 | HYP-IONS |
| 15 | CRSP | CRISPR THERAPEUTICS AG | Healthcare | 1.56% | $1,557,122 | HYP-CRSP |
| 16 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 1.50% | $1,504,656 | HYP-RLAY |
| 17 | ABCL | ABCELLERA BIOLOGICS INC | Healthcare | 1.43% | $1,429,478 | HYP-ABCL |
| 18 | NHC | NATIONAL HEALTHCARE CORP | Healthcare | 1.24% | $1,243,566 | HYP-NHC |
| 19 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 1.15% | $1,146,844 | HYP-IDYA |
| 20 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 1.14% | $1,140,441 | HYP-DNLI |
| 21 | XNCR | XENCOR INC | Healthcare | 1.08% | $1,077,692 | HYP-XNCR |
| 22 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 0.96% | $963,719 | HYP-RCUS |
| 23 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 0.94% | $936,714 | HYP-BEAM |
| 24 | CLDX | CELLDEX THERAPEUTICS INC | Healthcare | 0.84% | $844,022 | HYP-CLDX |
| 25 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 0.78% | $781,838 | HYP-VIR |
| 26 | SEPN | SEPTERNA INC | Healthcare | 0.75% | $749,673 | HYP-SEPN |
| 27 | BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.74% | $744,286 | HYP-BCRX |
| 28 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 0.74% | $743,307 | HYP-MAZE |
| 29 | ZBIO | ZENAS BIOPHARMA INC | Healthcare | 0.71% | $706,019 | HYP-ZBIO |
| 30 | ZYME | ZYMEWORKS INC | Healthcare | 0.69% | $688,204 | HYP-ZYME |
| 31 | STOK | STOKE THERAPEUTICS INC | Healthcare | 0.65% | $645,417 | HYP-STOK |
| 32 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 0.64% | $641,915 | HYP-NRIX |
| 33 | IMCR | IMMUNOCORE HOLDINGS PLC | Healthcare | 0.59% | $593,215 | HYP-IMCR |
| 34 | ABSI | ABSCI CORP | Healthcare | 0.59% | $590,465 | HYP-ABSI |
| 35 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 0.58% | $577,169 | HYP-RAPP |
| 36 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 0.56% | $557,735 | HYP-NTLA |
| 37 | ANAB | ANAPTYSBIO INC | Healthcare | 0.54% | $537,886 | HYP-ANAB |
| 38 | KRSA | KORSANA BIOSCIENCES INC | Healthcare | 0.54% | $536,530 | HYP-KRSA |
| 39 | OMER | OMEROS CORP | Healthcare | 0.49% | $490,504 | HYP-OMER |
| 40 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 0.48% | $479,016 | HYP-NKTR |
| 41 | MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | 0.32% | $317,963 | HYP-MGTX |
| 42 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 0.30% | $299,620 | HYP-GLUE |
| 43 | ALMS | ALUMIS INC | Healthcare | 0.30% | $298,829 | HYP-ALMS |
| 44 | JANX | JANUX THERAPEUTICS INC | Healthcare | 0.26% | $264,894 | HYP-JANX |
| 45 | KURA | KURA ONCOLOGY INC | Healthcare | 0.26% | $257,135 | HYP-KURA |
| 46 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 0.25% | $254,611 | HYP-AVBP |
| 47 | FDMT | 4D MOLECULAR THERAPEUTICS INC | Healthcare | 0.25% | $252,088 | HYP-FDMT |
| 48 | SRZN | SURROZEN INC | Healthcare | 0.23% | $227,380 | HYP-SRZN |
| 49 | CBIO | CRESCENT BIOPHARMA INC | Healthcare | 0.20% | $201,053 | HYP-CBIO |
| 50 | OBIO | ORCHESTRA BIOMED HOLDINGS INC | Healthcare | 0.18% | $182,296 | HYP-OBIO |
| 51 | ARVN | ARVINAS INC | Healthcare | 0.17% | $169,452 | HYP-ARVN |
| 52 | AVTX | AVALO THERAPEUTICS INC | Healthcare | 0.17% | $167,682 | HYP-AVTX |
| 53 | PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | 0.16% | $159,170 | HYP-PRTA |
| 54 | LYEL | LYELL IMMUNOPHARMA INC | Healthcare | 0.14% | $144,820 | HYP-LYEL |
| 55 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 0.12% | $122,861 | HYP-ENTA |
| 56 | AGEN | AGENUS INC | Healthcare | 0.12% | $117,061 | HYP-AGEN |
| 57 | EVMN | EVOMMUNE INC | Healthcare | 0.11% | $109,641 | HYP-EVMN |
| 58 | QTTB | Q32 BIO INC | Healthcare | 0.10% | $99,396 | HYP-QTTB |
| 59 | BIOA | BIOAGE LABS INC | Healthcare | 0.10% | $97,814 | HYP-BIOA |
| 60 | ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | 0.09% | $91,638 | HYP-ARCT |
| 61 | DTIL | PRECISION BIOSCIENCES INC | Healthcare | 0.08% | $84,594 | HYP-DTIL |
| 62 | TRDA | ENTRADA THERAPEUTICS INC | Healthcare | 0.08% | $76,233 | HYP-TRDA |
| 63 | KROS | KEROS THERAPEUTICS INC | Healthcare | 0.07% | $74,500 | HYP-KROS |
| 64 | KRRO | KORRO BIO INC | Healthcare | 0.07% | $73,973 | HYP-KRRO |
| 65 | RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | 0.07% | $72,994 | HYP-RNAC |
| 66 | STRO | SUTRO BIOPHARMA INC | Healthcare | 0.06% | $59,886 | HYP-STRO |
| 67 | CUE | CUE BIOPHARMA INC | Healthcare | 0.05% | $47,871 | HYP-CUE |
| 68 | RLYB | RALLYBIO CORP | Healthcare | 0.03% | $31,751 | HYP-RLYB |
| 69 | VTVT | VTV THERAPEUTICS INC | Healthcare | 0.03% | $31,261 | HYP-VTVT |
| 70 | GOSS | GOSSAMER BIO INC | Healthcare | 0.03% | $25,875 | HYP-GOSS |
| 71 | XLO | XILIO THERAPEUTICS INC | Healthcare | 0.02% | $21,921 | HYP-XLO |
| 72 | YARW | YARROW BIOSCIENCE INC | Healthcare | 0.02% | $19,736 | HYP-YARW |
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.